“Boston Scientific Corporation (NYSE: BSX) announces 510(k) clearance and the first cases of the SpyGlass DS Direct Visualization System used for cholangioscopy and pancreatoscopy procedures. Built on the technology of the original SpyGlass System, the new SpyGlass DS System is designed to optimiz
“Boston Scientific Corporation (NYSE: BSX) announces 510(k) clearance and the first cases of the SpyGlass DS Direct Visualization System used for cholangioscopy and pancreatoscopy procedures. Built on the technology of the original SpyGlass System, the new SpyGlass DS System is designed to optimiz
このブックマークにはスターがありません。
最初のスターをつけてみよう！
Boston Scientific Launches Next Generation SpyGlass™ DS Direct Visualization System For Advanced Diagnosis And Treatment Of Pancreatico-biliary Diseases
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／